[
  {
    "ts": null,
    "headline": "Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership",
    "summary": "Kriya’s $320 million raise ranks as one of the year’s largest private funding rounds. Elsewhere, a Genentech veteran joined Amgen and Merck and Daiichi touted results for a new kind of antibody-drug conjugate.",
    "url": "https://finnhub.io/api/news?id=33be676d416451db2dc19eb1bb13dc839db67235f49e989e18f331ae23aea73a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757507580,
      "headline": "Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership",
      "id": 136688957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Kriya’s $320 million raise ranks as one of the year’s largest private funding rounds. Elsewhere, a Genentech veteran joined Amgen and Merck and Daiichi touted results for a new kind of antibody-drug conjugate.",
      "url": "https://finnhub.io/api/news?id=33be676d416451db2dc19eb1bb13dc839db67235f49e989e18f331ae23aea73a"
    }
  },
  {
    "ts": null,
    "headline": "Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.",
    "summary": "While the EU and UK attempt to lure scientists with new financial incentives, Basel’s stable economy and emphasis on science remains a draw.",
    "url": "https://finnhub.io/api/news?id=b28040e0dd55cb8a50885830067c1799b807e6849ab6514102edae769db1bb7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757494800,
      "headline": "Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.",
      "id": 136688665,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "While the EU and UK attempt to lure scientists with new financial incentives, Basel’s stable economy and emphasis on science remains a draw.",
      "url": "https://finnhub.io/api/news?id=b28040e0dd55cb8a50885830067c1799b807e6849ab6514102edae769db1bb7a"
    }
  }
]